ADVIA CENTAUR TESTOSTERONE II (TSTII) N/A 10696862

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-01-04 for ADVIA CENTAUR TESTOSTERONE II (TSTII) N/A 10696862 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[63915729] The validation/method comparison was performed in parallel with fresh samples for both the testosterone ii (tstii) and testosterone (tsto) assays. The data was generated for validation purposes only. The customer is now using the testosterone ii (tstii) assay to generate patient results and is no longer using the testosterone (tsto) assay. The cause for the discordant testosterone results is unknown. Siemens healthcare diagnostics is investigating.
Patient Sequence No: 1, Text Type: N, H10


[63915730] Discordant advia centaur testosterone ii (tstii) results were obtained during validation/method comparison when compared to the advia centaur testosterone (tsto) results. Patient treatment was not prescribed or altered. There was no report of adverse health consequences due to the discordant testosterone ii (tstii) results.
Patient Sequence No: 1, Text Type: D, B5


[67547803] Siemens filed the initial mdr 1219913-2016-00264 on january 04, 2017. On 01/05/2016 correction: the date of event was (b)(6) 2016. The date received by the manufacturer was 12/15/2016. On 01/06/2016 additional information: the advia centaur testosterone ii (tstii) assay has been aligned to the cdc hormone standardization (host) program. Tstii also demonstrates improved lower end sensitivity and precision. Customers will observe a difference in results based on these changes. The customer should expect low patient values to run lower on tstii and high patient values to run higher on tstii. Internal correlation data (n=128 in range of 8. 60-1394 ng/dl) demonstrates an overall bias of <10%. The data generated by siemens is similar to what's been represented in the customer data. The tstii assay is also standardized to the cdc lc-ms/ms method. Customer bulletin 11222821, rev. B, introducing the advia centaur testosterone ii and standardized shbg assays on the advia centaur, xp and xpt systems was issued september 2016. The instrument is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2016-00264
MDR Report Key6223279
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-01-04
Date of Report2017-01-27
Date of Event2016-12-14
Date Mfgr Received2017-01-05
Device Manufacturer Date2016-02-24
Date Added to Maude2017-01-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR TESTOSTERONE II (TSTII)
Generic NameTESTOSTERONE IMMUNOASSAY
Product CodeCDZ
Date Received2017-01-04
Model NumberN/A
Catalog Number10696862
Lot Number001
Device Expiration Date2017-03-24
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2017-01-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.